RU2012137061A - PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND THEIR APPLICATION IN THE TREATMENT OF CEREBROVASCULAR DISORDERS - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND THEIR APPLICATION IN THE TREATMENT OF CEREBROVASCULAR DISORDERS Download PDFInfo
- Publication number
- RU2012137061A RU2012137061A RU2012137061/15A RU2012137061A RU2012137061A RU 2012137061 A RU2012137061 A RU 2012137061A RU 2012137061/15 A RU2012137061/15 A RU 2012137061/15A RU 2012137061 A RU2012137061 A RU 2012137061A RU 2012137061 A RU2012137061 A RU 2012137061A
- Authority
- RU
- Russia
- Prior art keywords
- cerebrovascular disorders
- amlodipine
- nicotinate
- treatment
- pharmaceutical composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Применение S-амлодипина никотината в лечении цереброваскулярных нарушений.2. Применение по п.1, где цереброваскулярные нарушения выбраны из группы: геморрагический инсульт, ишемический инсульт, в том числе глобальная преходящая ишемия.3. Фармацевтическая композиция для лечения цереброваскулярных нарушений, содержащая в качестве активного компонента S-амлодипина никотинат и фармацевтически приемлемые наполнители, отличающаяся тем, что содержит в качестве активного компонента S-амлодипина никотинат в эффективном количестве от 0,1 мг-50 мг на дозу.4. Фармацевтическая композиция по п.3, отличающаяся тем, что представляет собой таблетку либо твердую желатиновую капсулу, либо раствор для инъекций или инфузий.1. The use of S-amlodipine nicotinate in the treatment of cerebrovascular disorders. 2. The use according to claim 1, where the cerebrovascular disorders are selected from the group: hemorrhagic stroke, ischemic stroke, including global transient ischemia. A pharmaceutical composition for treating cerebrovascular disorders, containing nicotinate and pharmaceutically acceptable excipients as the active ingredient of S-amlodipine, characterized in that it contains nicotinate in an effective amount of 0.1 mg-50 mg per dose as the active ingredient of S-amlodipine. The pharmaceutical composition according to claim 3, characterized in that it is a tablet or a hard gelatin capsule, or a solution for injection or infusion.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012137061/15A RU2516922C2 (en) | 2012-08-30 | 2012-08-30 | Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012137061/15A RU2516922C2 (en) | 2012-08-30 | 2012-08-30 | Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012137061A true RU2012137061A (en) | 2014-03-10 |
RU2516922C2 RU2516922C2 (en) | 2014-05-20 |
Family
ID=50191390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012137061/15A RU2516922C2 (en) | 2012-08-30 | 2012-08-30 | Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2516922C2 (en) |
-
2012
- 2012-08-30 RU RU2012137061/15A patent/RU2516922C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2516922C2 (en) | 2014-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA109991C2 (en) | CARBAMATE COMPOUNDS, THEIR PREPARATION AND APPLICATION | |
EA202090573A1 (en) | COMPOSITIONS OF NIRAPARIBA | |
EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
EA201592250A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseases | |
EA201690223A1 (en) | FACTOR INHIBITORS IN THE COMPLEMENT BASED ON PIPERIDININILINDOL DERIVATIVES AND THEIR APPLICATION | |
EA201491285A1 (en) | IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID | |
EA201690287A1 (en) | 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY | |
EA201492290A1 (en) | COMPOSITIONS AND METHODS FOR VAGINAL DELIVERY OF ANTIPROGHESTINES | |
JP2015517488A5 (en) | ||
EA201491479A1 (en) | DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
EA201592255A1 (en) | DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE | |
RU2018135973A (en) | PHARMACEUTICAL COMBINATION CONTAINING METROFORMIN AND DYHYDROQUERCENINE, AND ITS APPLICATION FOR TREATING CANCER | |
EA201400067A1 (en) | NEW THERAPEUTIC COMPOSITION CONTAINING APOMORPHIN AS AN ACTIVE INGREDIENT | |
RU2019139886A (en) | THERAPEUTIC AGAINST DYSFUNCTION OF MEIBOMIUM GLANDS | |
RU2014129508A (en) | NEW COMBINATION | |
MX2017013636A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from different particles. | |
EA201501164A1 (en) | SOLID PHARMACEUTICAL MEDICINE FORM | |
EA201500513A1 (en) | SOMICRONIZATION PRODUCT, INCLUDING ULETRIDAL ACETATE | |
EA201490045A1 (en) | DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA | |
PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
EA201490573A1 (en) | CONTAINING BENZOTHIAZOLONE | |
EA201591653A1 (en) | COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL | |
MX2017005163A (en) | Onapristone extended-release compositions and methods. | |
EA201200754A1 (en) | TRADITIONAL CHINESE DRUG, CONTAINING DAN-SHEN EXTRACTS (DANSHEN) AND SAN-KI (SANQI), AND ITS APPLICATION | |
MX2017013633A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from particles. |